Efficacy and Safety of Rexlemestrocel-L Combined with HA* in Participants with Moderate to Severe Chronic Low Back Pain

Recruiting

Phase 3

Efficacy and Safety of Rexlemestrocel-L Combined with HA* in Participants with Moderate to Severe Chronic Low Back PainEfficacy and Safety of Rexlemestrocel-L Combined with HA* in Participants with Moderate to Severe Chronic Low Back Pain

Sponsor:

Mesoblast, Ltd.

Code:

NCT06325566

Conditions

Degenerative Disc Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rexlemestrocel-L + HA mixture

Saline

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Mesoblast, Ltd. on 2025-03-25.